Questionable drug patents that put lives at risk are finally starting to get more scrutiny. The Public Patent Foundation (better known as PUBPAT) is now challenging the validity of eight patents held by Abbott Labs around the HIV/AIDS drug ritonavir (branded Norvir). As PUBPAT noes, there's plenty of prior art that should have prevented these patents from ever being granted.

Earlier this year, we noted that scammers were copying the mass automated pre-settlement copyright infringement notices of law firms like ACS:Law and US Copyright Group, in order to get people to install malware on their computers. It appears that sort of effort is only expanding.

Salon's got a blood-boiling interview with Aaron Kupchik, author of Homeroom Security: School Discipline in an Age of Fear, a close look at four very different US schools.

We've seen plenty of stories of review or ranking sites that get sued by people upset about their reviews, but one such site that seems to get extra special attention is Avvo -- and that's because it's a ranking and review site for lawyers. Soon after the site was launched a few years back, it was sued -- leading a judge to dismiss the suit, pointing out that rankings are opinions and opinions are protected by that old First Amendment thing.

For many years, we've discussed how the Bayh-Dole Act, which created incentives for universities to patent the (often federally-funded) research results of professors, has been a dismal failure. The failure is based on the same faulty reason for why people think that patent system itself increases innovation -- even in the face of an awful lot of evidence to the contrary.

We recently wrote about Newsweek's coverage of Austin Heap and Haystack, a program he supposedly wrote to help Iranian internet users avoid being spied on by the Iranian government. Some of our commenters questioned the overall legitimacy of the story. It has a very too-perfect Hollywood sort of feel to it -- and some pointed out the fact that no one seems to be able to actually look at Haystack.